英文名稱 |
中文名稱 |
CAS號 |
操作 |
Cysteine Protease inhibitor hydrochloride |
4-((4'-(氨甲基)-[1,1'-聯苯]-3-基)氧基)嘧啶-2-腈鹽酸鹽 |
2197053-49-7 |
詳細
|
CHD1Li 6.11 |
化合物 CHD1LI 6.11 |
2716890-91-2 |
詳細
|
(Rac)-CP-601927 hydrochloride |
(RAC)-CP-601927 HYDROCHLORIDE |
230615-01-7 |
詳細
|
Cys-McMMAF |
|
1160590-05-5 |
詳細
|
Clitocine |
克力托辛 |
105798-74-1 |
詳細
|
Ceratotoxin A |
SER-ILE-GLY-SER-ALA-LEU-LYS-LYS-ALA-LEU-PRO-VAL-ALA-LYS-LYS-ILE-GLY-LYS-ILE-ALA-LEU-PRO-ILE-ALA-LYS-ALA-ALA-LEU-PRO |
150671-04-8 |
詳細
|
CDK5 inhibitor 20-223 |
CDK5 INHIBITOR 20-223 |
865317-30-2 |
詳細
|
CDC25B-IN-1 |
CDC25B-IN-1 |
2374831-10-2 |
詳細
|
Cimiracemoside C |
千層紙素A-7-0-Β-D-葡萄糖醛酸苷 |
256925-92-5 |
詳細
|
β-Cyclogeraniol |
2,6,6-trimethylcyclohexene-1-methanol |
472-20-8 |
詳細
|
CKLF1-C27 |
|
891861-48-6 |
詳細
|
CCR4-351 hydrochloride |
|
2174938-71-5 |
詳細
|
Cevipabulin |
5-氯-6-[2,6-二氟-4-[3-(甲基氨基)丙氧基]苯基]-N-((1S)-2,2,2-三氟-1-甲基乙基)-[1,2,4]三唑并[1,5-A]嘧啶-7-胺 |
849550-05-6 |
詳細
|
Combretastatin A-1 |
康普瑞汀A-1 |
109971-63-3 |
詳細
|
CGP77675 |
CGP 77675; CGP-77675 |
234772-64-6 |
詳細
|
CNX-1351 |
CNX1351 |
1276105-89-5 |
詳細
|
CRS3123 dihydrochloride |
REP 3123 DIHYDROCHLORIDE |
1013915-99-5 |
詳細
|
CCX354 |
1010073-75-2 |
1010073-75-2 |
詳細
|
CMP-5 |
1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine |
880813-42-3 |
詳細
|
CSN5i-3 |
化合物 T10895 |
2375740-98-8 |
詳細
|
CD73-IN-5 |
CD73-IN-5 |
2412019-99-7 |
詳細
|
(S)-Carvedilol |
(S)-(-)-卡維地洛 |
95094-00-1 |
詳細
|
Clomipramine-d3hydrochloride |
鹽酸氯米帕明-D3 |
1398065-86-5 |
詳細
|
CDK12-IN-3 |
CDK12-IN-3 |
2220184-50-7 |
詳細
|
Col003 |
COL003 |
328565-16-8 |
詳細
|
CXCR7 modulator 1 |
CXCR7 modulator 1 |
2231812-31-8 |
詳細
|
CXCR2-IN-2 |
CXCR2-IN-2 |
1838123-21-9 |
詳細
|
CCT128930 hydrochloride |
4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine hydrochloride |
2453324-32-6 |
詳細
|
(+)-Columbianetin |
二氫山芹醇 |
3804-70-4 |
詳細
|
Cimiracemoside D |
12Β-ACETOXYCIMIGENOL-3-O-Α-L-ARABINOPYRANSIDE |
290821-39-5 |
詳細
|
CuATSM |
CUAM |
68341-09-3 |
詳細
|
Cobimetinib hemifumarate |
可美替尼 |
1369665-02-0 |
詳細
|
CWP232228 |
化合物CWP232228 |
1144044-02-9 |
詳細
|
CU-CPT9b |
CPD1577 |
2162962-69-6 |
詳細
|
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA |
199807-33-5 |
199807-33-5 |
詳細
|
CM03 |
化合物 T23902 |
2101208-44-8 |
詳細
|
Cardiotoxin Analog (CTX) IV (6-12) |
Cardiotoxin Analog (CTX) IV (6-12) |
115722-23-1 |
詳細
|
Carcinoembryonic Antigen (CEA) |
癌胚抗原CEA |
168635-85-6 |
詳細
|
CDC25B-IN-2 |
化合物BIA |
134271-74-2 |
詳細
|
Calcitriol Impurities A |
(1R,3S,5E)-4-亞甲基-5-[(2E)-2-[(1R,3AS,7AS)-八氫-1-[(1R)-5-羥基-1,5-二甲基己基]-7A-甲基-4H-茚-4-亞基]亞乙基]-1,3-環(huán)己二醇 |
73837-24-8 |
詳細
|
Convallatoxin |
K-毒毛旋花子配質-3-L-鼠李糖甙 |
508-75-8 |
詳細
|
Carvedilol-d4 |
(±)-Carvedilol-d4 |
1133705-56-2 |
詳細
|
Cytarabine-d2 |
阿糖胞苷-D2氘代 |
40632-26-6 |
詳細
|
CCT-251921 |
CCT251921 |
1607837-31-9 |
詳細
|
CSRM617 hydrochloride |
鹽酸芐絲肼雜質C |
1353749-74-2 |
詳細
|
CID1231538 |
N-{2-[(4-chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(morpholin-4-ylcarbonyl)benzamide |
354126-20-8 |
詳細
|
CCB02 |
CCB02 |
2100864-57-9 |
詳細
|
Cyclo(his-pro) TFA |
Cyclo(his-pro) (TFA) |
936749-56-3 |
詳細
|
c-Fms-IN-8 |
c-Fms-IN-8 |
1255303-58-2 |
詳細
|
CU-115 |
化合物CU-115 |
2471982-20-2 |
詳細
|
Ceramides Mixture |
神經酰胺 |
100403-19-8 |
詳細
|
Camobucol |
216167-92-9 |
216167-92-9 |
詳細
|
CXCR2 antagonist 2 |
化合物 CXCR2 ANTAGONIST 2 |
2647464-91-1 |
詳細
|
Cathepsin X-IN-1 |
化合物CATHEPSIN X-IN-1 |
2418577-51-0 |
詳細
|
Cyhalofop |
氰氟草酸 |
122008-78-0 |
詳細
|
Cemdisiran |
ALN-CC5 |
1639264-46-2 |
詳細
|
Cleistanthin B |
山荷葉素 O-葡萄糖苷 |
30021-77-3 |
詳細
|
CLZ-8 |
MCL1-IN-8 |
678158-55-9 |
詳細
|
Cyclo(RADfK) |
整合素配體多肽Cyclo(Arg-Ala-Asp-d-Phe-Lys) |
756500-23-9 |
詳細
|
CDDO-EA |
CS-1305 |
932730-51-3 |
詳細
|
CCT251236 |
CCT251236 |
1693731-40-6 |
詳細
|
Cyclo(L-Phe-L-Val) |
(3S,6S)-3-芐基-6-異丙基哌嗪-2,5-二酮 |
35590-86-4 |
詳細
|
c-Fms-IN-1 |
C-FMS-IN-1 |
885703-64-0 |
詳細
|
CCG273441 |
化合物 CCG-273220 |
2750414-35-6 |
詳細
|
(+)-Columbianetin acetate |
二氫歐山芹醇醋酸酯 |
23180-65-6 |
詳細
|
Cefcapene pivoxil hydrochloride |
鹽酸頭孢卡品酯 |
147816-23-7 |
詳細
|
Calcium-Sensing Receptor Antagonists I |
1-(1-甲基乙基)-4-[4-(1-甲基乙基)苯基]-6-(2-丙炔-1-氧基)-2(1H)-喹唑啉 |
478963-79-0 |
詳細
|
Carboxy pyridostatin trifluoroacetate salt |
CARBOXYPYRIDOSTATIN TRIFLUOROACETATE SALT |
2444713-88-4 |
詳細
|
CMLD012612 |
CMLD012612 |
2368900-35-8 |
詳細
|
CRT0273750 |
3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]- |
1979939-16-6 |
詳細
|
(R,R)-CXCR2-IN-2 |
(R,R)-CXCR2-IN-2 |
1838123-22-0 |
詳細
|
CP-447697 |
4-[(苯并[B]噻吩-3-基羰基)[2-(4-氯苯基)乙基]氨基]-N-(2,4-二氟苯基)-1-哌啶甲酰胺 |
1092847-21-6 |
詳細
|
Cistanoside A |
肉蓯蓉苷A |
93236-42-1 |
詳細
|
Carboxylesterase-IN-3 |
化合物 CARBOXYLESTERASE-IN-3 |
2764748-92-5 |
詳細
|
CPA inhibitor |
ALPHA-[[羥基(2-苯基乙酰)氨基]甲基]苯丙酸 |
223532-02-3 |
詳細
|
CORM-401 |
CORM-401 |
1001015-18-4 |
詳細
|
CLK-IN-T3 |
CLK inhibitor T3
(T3) |
2109805-56-1 |
詳細
|
CSF1R-IN-1 |
CSF1R-IN-1 |
2095849-04-8 |
詳細
|
(R)-Carvedilol |
(R)-卡維地洛 |
95093-99-5 |
詳細
|
Cinnarizine-d8 |
八氘代桂利嗪 |
1185242-27-6 |
詳細
|
Cergutuzumab amunaleukin |
Cergutuzumab Amunaleukin |
1509916-03-3 |
詳細
|
Cearoin |
2,5-二羥基-4-甲氧基二苯甲酮 |
52811-37-7 |
詳細
|
Cipralisant maleate |
Cipralisant maleate |
223420-20-0 |
詳細
|
CWI1-2 |
N',N‘',2-三(5-氯-2-羥基亞芐基)肼-1-腙肼 |
2408590-36-1 |
詳細
|
Cauloside D |
葳巖仙皂苷 D |
12672-45-6 |
詳細
|
CZL55 |
化合物CZL55 |
667408-87-9 |
詳細
|
CCR2 antagonist 4 |
226226-39-7 |
226226-39-7 |
詳細
|
Calcipotriol Impurity C |
5,6-反式-卡泊三醇 |
113082-99-8 |
詳細
|
Corylifol A |
3-[3-[(2E)-3,7-二甲基-2,6-辛二烯-1-基]-4-羥基苯基]-7-羥基-4H-1-苯并吡喃-4-酮 |
775351-88-7 |
詳細
|
CP-640186 hydrochloride |
鹽酸CP-640186 |
591778-70-0 |
詳細
|
CI-1044 |
197894-84-1 |
197894-84-1 |
詳細
|
CPL304110 |
化合物 CPL304110 |
1627826-19-0 |
詳細
|
CCR4-351 |
CCR4 ANTAGONIST 3 |
2174938-70-4 |
詳細
|
Cephaloridine hydrate |
Cephaloridine Monohydrate |
102039-86-1 |
詳細
|
Cirsilineol |
甲基條葉薊素 |
41365-32-6 |
詳細
|
Carboxylesterase-IN-2 |
CARBOXYLESTERASE-IN-2 |
2764748-88-9 |
詳細
|
CD73-IN-4 |
化合物CD73-IN-4 |
2216764-29-1 |
詳細
|
Cyclooctyne-O-PFP ester |
Cyclooctyne-O-PFP ester |
886209-60-5 |
詳細
|
CellTracker Blue CMF2HC Dye |
CELLTRACKER BLUE CMF2HC DYE |
215868-45-4 |
詳細
|
Cholesterol 24-hydroxylase-IN-1 |
化合物 CHOLESTEROL 24-HYDROXYLASE-IN-1 |
1613480-70-8 |
詳細
|